Yourgene Health AAQS 2024

Yourgene Health AAQS

Ticker

YGEN.L

ISIN

GB00BN31ZD89

WKN

A116JH

Revenue Net Income P/E P/S EBIT Dividend Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE

Yourgene Health has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock Yourgene Health in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

Yourgene Health Aktienanalyse

What does Yourgene Health do?

Yourgene Health PLC is an international life science company specializing in the development and marketing of DNA tests for various areas of health. The company, based in Manchester, England, was founded in 2009 and has been listed on the London Stock Exchange since 2013. The business model of Yourgene Health is to offer genetic tests for a variety of applications in order to improve people's well-being, health, and quality of life. The company has extensive experience in developing DNA diagnostic tests and offers a wide range of solutions for different markets. One of the core divisions of the company is oncology. Here, Yourgene Health PLC develops innovative test methods to identify and combat cancer cells and their growth. Another important area is reproductive health, where the company offers prenatal testing as well as fertility analysis. In Yourgene Health's broad product range, there are prenatal tests for the examination of chromosomal abnormalities in the fetus, tests for the analysis of genetic risks for hereditary diseases or thyroid diseases. The company also offers tests for the detection of bacteria and viruses, which serve as companion tests for infections. One of Yourgene Health's newest products is the Covid-19 PCR test. This test is performed through nasal and throat swabs and can provide an accurate diagnosis of coronavirus infection within a few hours. The test was developed in 2020 and has since proven to be an important measure in containing the pandemic along the test-trace-isolate model. In recent years, Yourgene Health has made numerous collaborations and acquisitions to strengthen its market position in different countries. This includes the acquisition of the US company Elucigene Diagnostics, a provider of DNA test solutions for reproductive health, in 2021. As part of its growth strategy, the company has announced expansion plans for Asia, particularly for China and Japan. For this purpose, the subsidiary Yourgene Health Shanghai was established in 2019. Yourgene Health PLC is an innovative company operating in a rapidly growing market. Through continuous development of new innovative test methods, implementation of collaborations and acquisitions, and expansion into new markets, the company is well positioned to achieve further growth successes and improve global health for consumers. Yourgene Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Frequently Asked Questions about Yourgene Health stock

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Yourgene Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Yourgene Health

Our stock analysis for Yourgene Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yourgene Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.